At the 2025 Yale Innovation Summit, the Colton Center for Autoimmunity hosted a showcase of Colton-funded research projects from across the Consortium, highlighting the translational potential of cutting-edge autoimmune science. The session brought together researchers from the University of Pennsylvania, New York University, and Yale University to present work spanning novel therapeutics, biologics, and diagnostics — several of which have already attracted commercial interest or launched startup companies.
Presenters included Professor Taku Kambayashi and Professor Michela Locci of the University of Pennsylvania, Dr. Jun Wang of New York University, and Dr. James Hansen of Yale University.
Watch the full Colton Center for Autoimmunity Showcase from the 2025 Yale Innovation Summit
Featured Experts

Sara Baier, MEd
Associate Director of External Relations, Colton Consortium for Autoimmunity
Colton Center for Autoimmunity, Perelman School of Medicine, University of Pennsylvania
Jennifer Gillen, MBA
Administrative Manager, Judith & Stewart Colton Center for Autoimmunity (NYU)
Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health, New York University
Kenneth Hassinger
Director of Finance, Colton Consortium for Autoimmunity
Colton Center for Autoimmunity, Perelman School of Medicine, University of PennsylvaniaFeatured Projects

Novel Tools to Track and Manipulate Immune Cells in Autoimmunity Models
Developing a cell-labeling tool to map immune cell interactions in living tissue, this project identifies the drivers of skin-resident T cell persistence in psoriasis and potential targets for disease prevention.

Early Detection and Diagnosis of Autoimmune Diseases Using Foundation AI Models
Applying self-supervised AI to multi-modal electronic health records — integrating clinical notes, labs, and imaging — this project builds scalable diagnostic models to detect autoimmune diseases earlier and more precisely.
Featured Publications
Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Related News

A Growing Network Takes Stock: Highlights from the 2026 Colton Consortium Symposium
Global leaders in autoimmune research gathered for the 2025 Colton Consortium Symposium last month, sharing breakthroughs from foundational science to translational therapies and forging collaborations to improve patient lives worldwide.

$5M Gift Establishes Colton Center for Autoimmunity at Mount Sinai to Advance Precision Medicine for Autoimmune Diseases
A $5 million gift from Judith and Stewart Colton establishes a Colton Center for Autoimmunity at Mount Sinai, expanding the Colton Consortium and advancing precision, early-detection approaches to autoimmune disease research.

Yale Receives $2.5M Gift to Advance Autoimmune Research
A $2.5 million gift from the Colton Foundation will advance autoimmune research at Yale School of Medicine and strengthen collaboration across the Colton Consortium for Autoimmunity's four member institutions.